MedReleaf Australia’s subsidiary across the ditch has been granted a Medicinal Cannabis Supply Licence from the New Zealand Ministry of Health.
The licence will enable MedReleaf NZ to acquire starting material, cannabis-based ingredients and medical cannabis products, including the import of such products into New Zealand. The company has also been approved to supply three medicinal cannabis products. The company is planning launches for each into the New Zealand medical market early next year.
“This is an important milestone for MedReleaf Australia, our New Zealand subsidiary MedReleaf NZ and Aurora Enterprises, with all three teams having worked diligently with the Ministry of Health to obtain Registrations for three of our quality dried EU-GMP medical cannabis products,” said MedReleaf Australia CEO Russell Harding.
MedReleaf Australia has an exclusive partnership with Aurora Cannabis Enterprises; which is based in Canada.